Skip to main content

Table 1 Schedule of screening, enrollment and assessment

From: Relapse after conservative surgery combined with triptorelin acetate versus conservative surgery only in women with focal adenomyosis: study protocol for a multicenter, prospective, randomized controlled trial

Evaluation

Screening

Enrollment

Time of follow up after surgery (month)

3

6

12

18

24

30

36

Written consent

 

       

Inclusion/exclusion criteria

 

       

Medical history

        

Physical exam

        

Safety test (preoperative examination)

        

2D/3D-CDUS/MRI

 

FSH, E2, AMH, CA125

 

Side effects

  

VAS and NRS

 

SF-36 and FSFI

 

PBAC score

 

  1. 2D/3D-CDUS/MRI two/three-dimensional color doppler ultrasonography/magnetic resonance imaging, FSH follicle stimulating hormone, E2 estradiol, AMH anti-Muellerian hormone, CA125 cancer antigen 125, VAS visual analogue scale, NRS numeric rating scale, SF-36 Short Form-36 Health Survey, FSFI Female Sexual Function index, PBAC pictorial blood loss assessment chart